Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma
العنوان: | Timing of PD-L1 Blockade with Durvalumab May Affect Outcomes of CD19 CAR-T Cell Therapy for Relapsed/Refractory Large B-Cell Lymphoma |
---|---|
المؤلفون: | Alexandre Vinaud Hirayama, Salvatore Fiorenza, Jordan Gauthier, Jenna M. Voutsinas, Qian Vicky Wu, Erik L. Kimble, Barbara S. Pender, Delaney R. Kirchmeier, Henna A. Di, Ryan D. Cassaday, Aude G. Chapuis, Damian J. Green, Hans-Peter Kiem, Filippo Milano, Mazyar Shadman, Brian G. Till, Stanley R. Riddell, David G. Maloney, Cameron J. Turtle |
المصدر: | Blood. 140:7447-7449 |
بيانات النشر: | American Society of Hematology, 2022. |
سنة النشر: | 2022 |
مصطلحات موضوعية: | Immunology, Cell Biology, Hematology, Biochemistry |
تدمد: | 1528-0020 0006-4971 |
URL الوصول: | https://explore.openaire.eu/search/publication?articleId=doi_________::f6ccf9df348782fb94a86d508def73fb https://doi.org/10.1182/blood-2022-168185 |
رقم الأكسشن: | edsair.doi...........f6ccf9df348782fb94a86d508def73fb |
قاعدة البيانات: | OpenAIRE |
كن أول من يترك تعليقا!